AzTrials
AzTrials

Deglutition DisordersSHUBACANCT06630013

A New Ultrasound Score for Swallowing Disorders Diagnosis in Difficult-to-wean Tracheostomised Patients

An observational study of Deglutition Disorders, run by Hopital Forcilles at 4 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Swallowing Disorders (SD) is commonly observed in intensive care unit (ICU) patients. Disruption to the upper airway by way of a tracheostomy may lead to physiological and/or biomechanical changes to the swallow, thereby increasing dysphagia risk. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Deglutition Disorders
How many people
114 participants
Where
4 sitesFrance
Study dates
9 Jul 2024to 6 Feb 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study will enroll one hundred and nineteen difficult-to-wean tracheostomised patients at Critical Care services of Forcilles's Hospital, Universitary Hospital of Dijon, Béthune Hospital and Bourgon Jallieu Hospital.

Who may be able to join

  • Patients admitted to ICU and tracheostomised for difficult-to-wean reasons ;
  • Patients with a medical indication for nasofibroscopy ;
  • Medical prescription for physiotherapy assessment ;
  • Ultrasound operator available ;
  • Patient at least 18 years old at the time of inclusion;
  • Oral, free, informed and express patient consent

Who cannot join

  • Patient with total laryngectomy;
  • History of swallowing disorders prior to critical care admission;
  • History of central nervous system disorders (stroke, Parkinson's disease, etc.)
  • Patient admitted to intensive care following central neurological injury;
  • Patient with spinal cord injury above C5 ;
  • Patient's refusal to participate in the study ;
Show all 10Show fewer
  • Known pregnancy ;
  • Cognitive impairment incompatible with understanding instructions;
  • Patient under guardianship;
  • Patient with limited care.

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

LE NEINDRE Aymeric, PhD contact

+33160646093

aleneindre@cognacq-jay.fr

DIAZ LOPEZ Carlos, PhD st contact

+33160646130

cdiaz.physio@gmail.com

France4 sites, 4 recruiting
  • Ch de Béthune

    Beuvry, Beuvry, 62660

    COMPERE Marine, MsC, +333 21 64 44 44, mcompere@hotmail.com

    COMPERE Marine

    Not yet recruiting
  • CHU Dijon Bourgogne

    Dijon, Bourgogne-Franche-Comté, 21231

    PINEDA MASEGOSA José Arturo, MsC, josearturo.pinedamasegosa@chu-dijon.fr

    PINEDA MASEGOSA José Arturo, MsC

    Not yet recruiting
  • Hôpital Forcilles

    Férolles-Attilly, 77150

    Aymeric Le Neindre, PhD, +33160646093, aleneindre@cognacq-jay.fr

    Carlos DIAZ LOPEZ, PhD st

    Recruiting
  • Groupement Hospitalier Nord Dauphiné, CH Bourgoin-Jallieu

    Lyon, Lyon, 38302

    COTTIN Antoine, MsC, +33469157000, antoine.cottin@ghnd.fr

    COTTIN Antoine, MsC

    Recruiting

Other trials in France

About this study

Official title: Construction and Evaluation of a New Ultrasound Score for the Diagnosis of Swallowing Disorders in Difficult-to-wean Tracheostomised Patients

Swallowing Disorders (SD) is commonly observed in intensive care unit (ICU) patients.

Disruption to the upper airway by way of a tracheostomy may lead to physiological and/or biomechanical changes to the swallow, thereby increasing dysphagia risk. SD is independently associated with adverse outcomes including respiratory complications, nutritional compromise, and even death.

Read more

Experts recommend a systematic bedside screening. Most algorithms include the water swallow test followed by expert comprehensive swallowing assessments of screening positive patients.

However, the clinical examination lacks precision. Complementary examinations, such as videofluoroscopy or Fiberoptic Endoscopic Evaluation of Swallowing (FEES), are irradiating or invasive, consume numerous resources and are difficult to access. No current consensus exists on how to best approach to evaluate ICU patients at risk.

In this context, US imaging has garnered increased interest for assessing swallowing disorders. Recognised for its non-invasive nature and its ability to overcome conventional constraints, this approach, enabling both qualitative and quantitative analysis of multiple structures, would enhance the precision in targeting structures for rehabilitation.

The researchers intend to create an ultrasound diagnostic model for difficult-to-wean trahceostomised patients. Additionally, they aim to evaluate the reliability and accuracy of this model.

During an nineteen-months period, we will enrolled one hundred and nineteen difficult-to-wean tracheostomised patients at Forcilles's Hospital, Universitary Hospital of Dijon, Béthune Hospital and Bourgon Jallieu Hospital.

All patients will have a FEES evaluation. The ultrasonographer will be blinded to the patient's status and prior clinical or imaging assessments. Ultrasound assessment will focus on evaluating the movements or morphology of structures such as the tongue, laryngeal movement, or suprahyoid muscles.

A global ultrasound diagnostic model will be developed after selecting variables in logistic multivariable regression. Its sensitivity and specificity and prediction value will be estimated. The constructed model will be transformed in an easy-to-use scoring system.

The study anticipates establishing an association between ultrasound markers and swallowing disorders, aiming to enhance early detection for tailored management strategies, providing a non-invasive alternative to videofluoroscopy or FEES.

Read the detailed description

Intensive Care Unit (ICU) stays often lead to Swallowing Disorders (SD). Physiological and biomechanical changes due to tracheostomy increase the risk of SD, which can have serious consequences for quality of life and overall health.

Experts recommend systematic bedside screening. Most algorithms include the water swallow test followed by expert comprehensive swallowing assessments of screening-positive patients. Early intervention strategies could greatly benefit, highlighting the importance of assessments identifying which specific structures require intervention and enabling a targeted rehabilitation approach. However, clinical examinations lack precision.

Complementary examinations, such as videofluoroscopy or Fiberoptic Endoscopic Evaluation of Swallowing (FEES), are irradiating or invasive, consume numerous resources, and are difficult to access. In this context, ultrasound imaging has garnered increased interest for assessing swallowing disorders. Recognized for its non-invasive nature and its ability to overcome conventional constraints, ultrasound holds promise in integrating morphological and dynamically swallowing-related structures evaluation. This approach, enabling both qualitative and quantitative analysis of multiple structures, would enhance precision in targeting structures for rehabilitation.

A recent study shows strong potential for an ultrasound prediction model for diagnosing swallowing disorders in outpatients. The researchers intend to create an ultrasound diagnostic model for difficult-to-wean tracheostomized patients. Additionally, they aim to evaluate the reliability and accuracy of this model. Hypothesis: The investigators hypothesize that an ultrasound predictive model is valid and reliable for diagnosing swallowing disorders in difficult-to-wean tracheostomized patients.

Main objective: The primary aim is to develop an ultrasound predictive model based on the most relevant ultrasound measurements of the aerodigestive tract.

Secondary objectives:

  • To evaluate the validity and reliability of a new ultrasound score for diagnosing swallowing disorders.
  • To assess the reliability and validity of tongue movement in diagnosing swallowing disorders.
  • To evaluate the reliability and validity of hyoid bone movement in diagnosing swallowing disorders.
  • To assess the reliability and validity of digastric muscle ultrasound evaluation in diagnosing swallowing disorders.
  • To evaluate the reliability and validity of genohyoid muscle ultrasound evaluation fraction in diagnosing swallowing disorders.

Study design:

This prospective observational multicenter study will adhere to the ethical standards of the Declaration of Helsinki and will be reported according to the standards for transparent reporting of a multivariable prediction model for individual prognosis or diagnosis guidelines (TRIPOD).

Population:

One hundred and nineteen difficult-to-wean tracheostomized patients will be enrolled. All consecutive patients with difficult-to-wean tracheostomies will be screened, and those meeting the eligibility criteria will be enrolled. Patients will provide oral consent to participate in accordance with French clinical research laws. Data collection, Fiberoptic Endoscopic Evaluation of Swallowing (FEES), and ultrasound (US) evaluations will be conducted within a two-hour timeframe.

Data collection:

Data will be recorded using an online case report form (Datacapt). Demographic data, comorbidities, medical, and surgical history will be recorded at enrollment. On-site monitoring is planned monthly.

Ultrasound examination:

Ultrasonography will be performed using both linear and convex probes. The ultrasonographer will be blinded to the patient's status and prior clinical or imaging assessments. All measurements will be performed in a semi-recumbent position (30°) with the neck in a neutral position. Subjects will be asked to swallow saliva to assess active movements and muscle contractions. Parameters such as tongue thickness, movement, and echointensity, hyoid bone movement, and suprahyoid muscle characteristics (thickness, cross-sectional area, and echointensity) will be evaluated. Suprahyoid muscles will be assessed both at rest and during swallowing, and muscle contraction ratios will be calculated accordingly. Detailed information on the ultrasound procedure is described in the research protocol.

To assess inter-examiner reliability, during the initial ultrasound evaluation, tests will be conducted by two different operators on a consecutive sample of patients. To limit the examination time for each patient, another consecutive sample of patients will be used for intra-examiner reliability. For the patients involved in the reliability assessment, an additional 10 minutes will be allocated.

FEES:

They will be performed by the attending physician in the patient's room. A physiotherapist or speech-language therapist will be present to assess swallowing and the involved structures systematically.

Evaluators will examine the integrity and functionality of structures such as the arytenoids or vocal cords, and assess laryngeal and hypopharyngeal sensitivity. The examination will conclude with swallowing trials using various textures to observe swallowing, enabling identification of any inhalation. Different bolus consistencies, viscosities, and volumes will be used during the assessment to evaluate the patient's full range of dietary options, based on preswallow assessments. The Yale Pharyngeal Residue Severity Rating Scale will be used to characterize the severity and localization of residues observed after each swallowing trial.

Statistical plan:

Descriptive statistics will summarize quantitative variables with means (± standard deviation) or medians [minimum-maximum], while qualitative variables will be described using numbers and percentages. Univariate comparisons will employ standard statistical tests, such as Chi-square, Fisher's test, t-test, ANOVA, Wilcoxon, or Kruskal-Wallis tests, with a significance level of 5% and 95% confidence intervals. Association measures between variables will use Pearson's or Spearman's correlation coefficients for quantitative data and Chi-square or Fisher's tests for qualitative data. Agreement assessment will utilize the Bland-Altman method for quantitative variables and the Kappa coefficient for qualitative variables.

To establish an ultrasound diagnostic model for diagnosing swallowing disorders, variables will be dichotomized based on a linear relationship hypothesis tested using ROC curve analysis. Patients will be categorized into positive (presence of swallowing disorders) and negative groups (absence of swallowing disorders) using FEES diagnosis. Ultrasound variables differing significantly between these groups (p < 0.20) will be included in multivariate logistic regression, guided by Akaike's information criterion (AIC) for variable selection while considering multicollinearity. The multivariate logistic regression scores will weight each ultrasound variable. Researchers will transform the model into an easy-to-use scoring system.

Validity will be determined by ROC curve analysis to establish the ultrasound score threshold for diagnosing swallowing disorders. Sensitivities, specificities, positive and negative predictive values, and diagnostic odds ratios will assess the score's diagnostic accuracy. Reliability, assessed with a correlation coefficient (ρ=0.80), requires a sample of 20 patients for a desired correlation coefficient (ρ0=0.50), ensuring sufficient power (α=0.05, β=0.20). Inter- and intra-examiner reproducibility will be evaluated using the Kappa coefficient.

Sample size calculation:

According to Harrell's recommendations on the construction of multivariate models, a maximum of 1 variable per 10 events should be included. The prevalence of swallowing disorders in our patient population is highly variable in the literature (e.g., 11-93% according to Skoretz or 50-83% according to Garuti et al). Based on our PMSI data, we estimate the prevalence of swallowing disorders at 65%. We aim to include a maximum of 4 variables in the multivariate model, i.e., 114 patients are required.

Medical subject headings
Deglutition Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Swallowing disorders prediction model development

    Selection of the most contributive ultrasound measures in the swallowing disorders diagnostic predictive model.

    The morphology and/or movement of the tongue, hyoid bone and suprahyoid muscles measured by ultrasound on swallowing disorder diagnosis

    Measured: The day of FEES evaluation during two hour time-frame

Secondary outcomes (3)
  1. Accuracy and reliability of tongue morphologic and kinematics characteristics on swallowing disorder diagnosis

    Ultrasound evaluation of tongue thickness and movement at rest et during swallow

    Measured: The day of FEES evaluation during two hour time-frame

  2. Accuracy and reliability of hyoid movement on swallowing disorder diagnosis

    Hyoid bone displacement will be recorded during swallowing and measured by assessing the distance between the hyoid and mandible at rest and at maximum approach.

    Measured: The day of FEES evaluation during two hour time-frame

  3. Accuracy and reliability of suprahyoid muscles characteristics on swallowing disorder diagnosis

    Linear transducer will be used to obtain a coronal plane of suprahyoid muscles. Suprahyoid muscles cross sectional area will be recorded and measured in square centimeters.

    Measured: The day of FEES evaluation during two hour time-frame

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start9 Jul 2024
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion6 Feb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
114 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06630013
Sponsor's protocol ID
2024-A00285-42
Acronym
SHUBACA
Status last verified
Sep 2026
First submitted
4 Oct 2024
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Deglutition Disorders, run by Hopital Forcilles at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact LE NEINDRE Aymeric, PhD (+33160646093, aleneindre@cognacq-jay.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Swallowing disorders prediction model development (time frame: The day of FEES evaluation during two hour time-frame). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in